REACTIVATION OF VESTIGIAL GENE. “We demonstrate here that gene therapeutic HDAd-mCMV-Gulo vectors can mediate the expression of GULO and endogenous production of ascorbic acid in human cells and in Gulo(-/-) transgenic mice. Taken together, these data show that a gene therapy approach can be successfully employed in the treatment and further study of vitamin C deficiency in scurvy-prone mammals.”
https://www.ncbi.nlm.nih.gov/pubmed/18764764
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022